Cas 1632250-50-0,N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride

1632250-50-0

Post Buying Request

Basic information

Product Name: N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride
Synonyms:
CAS NO:1632250-50-0
Molecular Formula:
Molecular Weight: 470.361
EINECS: N/A
Product Categories: N/A
Mol File: 1632250-50-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride(1632250-50-0)
EPA Substance Registry System: N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride(1632250-50-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1632250-50-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1632250-50-0 Suppliers

Recommended suppliersmore

1632250-50-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1632250-50-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,3,2,2,5 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1632250-50:
(9*1)+(8*6)+(7*3)+(6*2)+(5*2)+(4*5)+(3*0)+(2*5)+(1*0)=130
130 % 10 = 0
So 1632250-50-0 is a valid CAS Registry Number.

1632250-50-0Upstream product

1632250-50-0Downstream Products

1632250-50-0Relevant articles and documents

SUBSTITUTED AMIDE COMPOUNDS

-

Paragraph 0660; 0791; 0795; 0796; 0797; 0798; 0799, (2014/10/29)

The present invention is directed at substituted amide compounds, pharmaceutical compositions containing such compounds and the use of such compounds to reduce plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1632250-50-0